6q deletion in Waldenstrom macroglobulinemia is associated with features of adverse prognosis

被引:68
|
作者
Ocio, E. M.
Schop, R. F. J.
Gonzalez, B.
Van Wier, S. A.
Hernandez-Rivas, J. M.
Gutierrez, N. C.
Garcia-Sanz, R.
Moro, M. J.
Aguilera, C.
Hernandez, J.
Xu, R.
Greipp, P. R.
Dispenzieri, A.
Jalal, S. M.
Lacy, M. Q.
Gonzalez-Paz, N.
Gertz, M. A.
San Miguel, J. F.
Fonseca, R.
机构
[1] Hosp Univ Salamanca, Dept Hematol, Salamanca 37007, Spain
[2] Univ Salamanca, Dept Hematol, Ctr Invest Canc, E-37008 Salamanca, Spain
[3] Mayo Clin, Coll Med, Div Hematol, Rochester, MN USA
[4] Hosp Virgen Blanca Leon, Dept Hematol, Leon, Spain
[5] Hosp Gen Segovia, Dept Hematol, Segovia, Spain
关键词
DNA deletions; Waldenstrom macroglobulinemia; fluorescence in situ hybridisation; prognostic; 6q deletion;
D O I
10.1111/j.1365-2141.2006.06389.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Fluorescence in situ hybridisation (FISH) is an effective technique for the cytogenetic analysis of Waldenstrom macroglobulinemia (WM), but the potential impact of molecular cytogenetics on disease evolution and as a prognostic marker is still unknown. Deletion of the long arm of chromosome 6 (6q-) is the most frequent cytogenetic abnormality in WM. This study analysed the prevalence of this aberration in 102 WM patients, and correlated it with disease characteristics. The incidence of 6q21 deletion was 7% by conventional cytogenetics and 34% when analysed by FISH (54% when cytoplasmic immunoglobulin M-FISH was used). Patients with deletion of 6q displayed features of adverse prognosis, such as higher levels of beta 2-microglobulin and monoclonal paraprotein and a greater tendency to display anaemia and hypoalbuminemia. Interestingly, there was a correlation between the presence of 6q deletion and the International Staging System prognostic index (incidence of 6q- among patients stratified in stages 1, 2 and 3 was 24%, 42% and 67% respectively). Those patients diagnosed with smouldering WM who displayed the abnormality showed a trend to an earlier requirement of treatment. Finally, the survival analysis did not show differences between the two groups of patients, probably due to the short
引用
收藏
页码:80 / 86
页数:7
相关论文
共 50 条
  • [1] Analysis of 6q deletion in Waldenstrom macroglobulinemia
    Chang, Hong
    Qi, Xiaoying
    Xu, Wei
    Reader, Jocelyn C.
    Ning, Yi
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2007, 79 (03) : 244 - 247
  • [2] Inflammation in Waldenstrom macroglobulinemia is associated with 6q deletion and need for treatment initiation
    Forgeard, Nathalie
    Baron, Marine
    Caron, Jonathan
    Boccon-Gibod, Clementine
    Krzisch, Daphne
    Guedes, Nayara
    Morel, Veronique
    Jacque, Nathalie
    Ouzegdouh, Maya
    Choquet, Sylvain
    Bravetti, Clotilde
    Nguyen-Khac, Florence
    Chapiro, Elise
    Leblond, Veronique
    Roos-Weil, Damien
    HAEMATOLOGICA, 2022, 107 (11) : 2720 - 2724
  • [3] Inflammation in Waldenstrom macroglobulinemia is associated with 6q deletion and need for treatment initiation
    Forgeard, Nathalie
    Baron, Marine
    Caron, Jonathan
    Boccon-Gibod, Clementine
    Krzisch, Daphne
    Guedes, Nayara
    Morel, Veronique
    Jacque, Nathalie
    Ouzegdouh, Maya
    Choquet, Sylvain
    Bravetti, Clotilde
    Nguyen-Khac, Florence
    Chapiro, Elise
    Leblond, Veronique
    Roos-Weil, Damien
    French Innovat Leukemia Organizat Grp
    HAEMATOLOGICA, 2022, 107 : 2720 - 2724
  • [4] Evaluation of 6q Deletion in Waldenstrom's Macroglobulinemia, a Multicenter Collaborative Study
    Chang, H.
    Qi, C.
    Trieu, Y.
    Jiang, A.
    Xu, W.
    Reece, D.
    Chen, C.
    Young, K. H.
    Chesney, A.
    Jani, P.
    Wang, C.
    Padmore, R.
    LABORATORY INVESTIGATION, 2009, 89 : 257A - 258A
  • [5] Prognostic Relevance of 6q Deletion in Waldenstrom's Macroglobulinemia: A Multicenter Study
    Chang, Hong
    Qi, Connie
    Trieu, Young
    Jiang, Allan
    Young, Ken H.
    Chesney, Alden
    Jani, Prashant
    Wang, Chen
    Reece, Donna
    Chen, Christine
    CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (01): : 36 - 38
  • [6] Evaluation of 6q Deletion in Waldenstrom's Macroglobulinemia, a Multicenter Collaborative Study
    Chang, H.
    Qi, C.
    Trieu, Y.
    Jiang, A.
    Xu, W.
    Reece, D.
    Chen, C.
    Young, K. H.
    Chesney, A.
    Jani, P.
    Wang, C.
    Padmore, R.
    MODERN PATHOLOGY, 2009, 22 : 257A - 258A
  • [7] Gene Expression Profile Signature of Aggressive Waldenstrom Macroglobulinemia with Chromosome 6q Deletion
    Sekiguchi, Naohiro
    Nomoto, Junko
    Nagata, Akihisa
    Kiyota, Masahiro
    Fukuda, Ichiro
    Yamada, Kazuaki
    Takezako, Naoki
    Kobayashi, Yukio
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [8] Analysis of 6q deletion inWaldenstrom macroglobulinemia
    Qi, C.
    Xu, W.
    Reader, J. C.
    Ning, Y.
    Chang, H.
    MODERN PATHOLOGY, 2007, 20 : 256A - 256A
  • [9] MYD88 MUTATIONS ARE CORRELATED WITH 6Q DELETION IN KOREAN PATIENTS WITH WALDENSTROM MACROGLOBULINEMIA
    Kim, J. A.
    Im, K.
    Park, S. N.
    Kwon, J.
    Choi, Q.
    Hwang, S. M.
    Sekiguchi, N.
    Yoon, S. S.
    Kim, S. Y.
    Lee, D. S.
    HAEMATOLOGICA, 2014, 99 : 651 - 651
  • [10] 6q deletion discriminates Waldenstrom macroglobulinemia from IgM monoclonal gammopathy of undetermined significance
    Schop, Roelandt F. J.
    Van Wier, Scott A.
    Xu, Ruifang
    Ghobrial, Irene
    Ahmann, Gregory J.
    Greipp, Philip R.
    Kyle, Robert A.
    Dispenzieri, Angela
    Lacy, Martha Q.
    Rajkumar, S. Vincent
    Gertz, Morie A.
    Fonseca, Rafael
    CANCER GENETICS AND CYTOGENETICS, 2006, 169 (02) : 150 - 153